Ropinirole
Requip, Requip Xl (ropinirole) is a small molecule pharmaceutical. Ropinirole was first approved as Requip on 1997-09-19. It is used to treat parkinson disease in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. Requip's patents are valid until 2021-12-02 (FDA).
Trade Name | Requip, Requip Xl |
---|---|
Common Name | Ropinirole |
Indication | parkinson disease |
Drug Class |